This is big news for me because I am allergic to the mRNA vaccines.
CDC clears Novavax Covid-19 vaccine for adults, says shots will be available in the coming weeks
[URL unfurl="true"]https://www.cnbc.com/2022/07/19/covid-cdc-panel-recommends-novavax-vaccine-for-adults.html[/URL]
- The Centers for Disease Control and Prevention signed off on Novavax’s Covid-19 vaccine on Tuesday.
- In a statement, the CDC said the shots will be available in the coming weeks. The U.S. has secured 3.2 million doses so far.
- Novavax uses more conventional technology than Pfizer and Moderna, and U.S. health officials hope Novavax’s shots might convince skeptics to get vaccinated.
- 26 million to 37 million adults are still unvaccinated in the U.S., according to CDC estimates.
The CDC, in a statement, said the vaccine will be available to the public in the coming weeks. The Biden administration has secured 3.2 million doses of Novavax’s vaccine so far, according to the Health and Human Services Department.
Walensky, in a statement, said the Novavax vaccine will provide another option for people who do not want to take Pfizer’s and Moderna’s shots. Anywhere from 26 million to 37 million adults are still unvaccinated in the U.S., according to CDC data, but it’s unclear how many of those people will opt to take Novavax’s vaccine.
“The primary target population for Novavax will be the 10% to 13% of those that are unvaccinated,” said Dr. Oliver Brooks, a CDC vaccine committee member and chief medical officer at Watts HealthCare Corporation in Los Angeles.
“I understand we’re really focused on that population with the hope that perhaps this protein subunit vaccine will change them over from being unvaccinated to vaccinated,” Brooks said.
